After 48 h of IL-21 treatment, we observed a significant apoptosis reduction in these cells (Fig. 1a) compared to the significantly increased apoptosis in EBV-negative DLBCL primary tumours under similar conditions as previously reported16. This evidence concerns the gene IL21 and diffuse large B-cell lymphoma.